About the Company
Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease. The company's SYMJEPI (epinephrine) Injection products are approved by the FDA for use in the emergency treatment of acute allergic reactions, including anaphylaxis. Adamis' naloxone injection product candidate, ZIMHI, for the treatment of opioid overdose is currently under FDA review. Adamis is developing additional products, including treatments for acute respiratory diseases, such as COVID-19, influenza, asthma, and COPD. The company's subsidiary, US Compounding Inc., compounds sterile prescription drugs, and certain nonsterile drugs for human and veterinary use by hospitals, clinics, surgery centers, and vet clinics throughout most of the United States. Forward Looking Statements
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ADMP News
Adamis Pharmaceuticals Corporation (ADMP)
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Adamis Pharmaceuticals Corp
29 Mar 2023 / 8:00 PM UTCQ4 2022 Adamis Pharmaceuticals Corp Earnings Release 15 May 2023 / 10:59 AM UTCQ1 2023 Adamis Pharmaceuticals Corp Earnings Release ...
Allergy Immunotherapy Market to Set Incredible Growth from Key Players | Circassia, Adamis Pharmaceuticals Corporation, Stallergenes Greer plc
A novel research study on Allergy Immunotherapy Market has been recently published by Fior Markets covering the latest trends and key market developments. The report is released with a ...
Fluticasone Market 2023 : Top Countries Data with Growth Rate Competitive Landscape and Forecast To 2028
Eupraxia Pharma, Innoviva, Adamis Pharma and Merz Pharma, etc. In 2021, the global top five players have a share approximately in terms of revenue. Global Fluticasone Scope and Segment Fluticasone ...
Stella Pharma Corp Stock (OTC:STPHF), Quotes and News Summary
Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT).
Cosmos Pharmaceutical Corp (3349)
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
New Suit - Patent
Counsel have not yet appeared for the defendants. The case is 1:23-cv-00026, Novartis Pharmaceuticals Corporation v. Hec Pharm Co., Ltd. et al.
Phio Pharma Stock (NASDAQ:PHIO), Quotes and News Summary
Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and ...
TNXP Tonix Pharmaceuticals Holding Corp.
The chart has 1 X axis displaying Time. Data ranges from 2022-01-13 00:00:00 to 2023-01-13 00:00:00. The chart has 1 Y axis displaying values. Data ranges from -96.83 to 0.08.
NervGen Pharma Stock (OTC:NGENF), Quotes and News Summary
NervGen Pharma Corp is a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases. The company is developing drugs for the ...
Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus.
Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Announces Reverse Stock Split
MARLBOROUGH, Mass., Jan. 25, 2023 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL RNAi platform technology is designed ...
Loading the latest forecasts...